The other real biggie in the short term is the first read out from the COVID-19 / ARDS trial in September.
I suspect normal very high levels of efficacy may not apply when it comes to halting the trial early, the FDA is desperately seeking Medical Counter Measures. If remestemcel-L does make the grade as a MCM for COVID-19 / ARDS I would expect the granting an Emergency Use Authorisation in days, a week at most.
MSB Trading 2020 - a new dawn, page-1171
-
- There are more pages in this discussion • 11,900 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.043(3.60%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.14 | $1.677M | 1.458M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 103507 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 16633 | 6 |
View Market Depth
| Last trade - 11.02am 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |